Safely Discontinuing Blood Pressure Medication: A Stepwise Approach

Stopping antihypertensives requires medical supervision. Abrupt cessation can cause rebound hypertension, tachycardia, or destabilization.

Stepwise Protocol (Typical)

1. Assess indication: Is HTN primary (lifestyle-responsive) or secondary? Is there compelling indication (HF, post-MI, CKD, diabetes) requiring lifelong therapy?
2. Lifestyle optimization FIRST: 3–6 months of:
   • DASH diet / Mediterranean (low Na, high K).
   • Weight loss if overweight (1 kg ≈ 1 mmHg BP drop).
   • Exercise: 150 min/week moderate aerobic + resistance.
   • Alcohol ≤1 drink/day (women), ≤2 (men).
   • Smoking cessation.
   • Stress reduction (meditation, sleep).
3. Home BP monitoring: Validated device, proper technique, log 7 days pre-visit.
4. Gradual taper (if BP controlled):
   • Reduce one drug at a time.
   • Halve dose → monitor 2–4 weeks → discontinue if stable.
   • Prefer stopping diuretic or beta-blocker last (rebound risk).
5. Follow-up: q2–4 weeks during taper; then q3–6 months.
6. Restart criteria: Home avg ≥130/80 on 2+ occasions; symptoms; target organ damage progression.

Special Considerations

• Beta-blockers: Taper slowly (rebound tachycardia, ischemia).
• Clonidine: Never stop abruptly (rebound hypertensive crisis).
• Combination pills: Separate components to taper individually.
• Pregnancy: Switch to pregnancy-safe agents (methyldopa, labetalol, nifedipine) — do not stop.

When NOT to Stop

• Secondary hypertension (renal artery stenosis, pheo, hyperaldosteronism).
• Compelling indications: HFrEF, post-MI, CKD with proteinuria, diabetes with albuminuria, prior stroke.
• Uncontrolled BP on current regimen.

Shared decision-making with your physician is essential. Many patients need lifelong therapy; that's okay — it prevents stroke, heart failure, kidney failure.